This analysis measures the impact of advertising on smoking cessation drugs, highlighting access barriers' role.
This paper measures the effects of direct-to-consumer advertising for smoking cessation prescription drugs and examines how access barriers moderate these effects.
No takes yet. Share an insight, caveat, or question.
Loghmani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: